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The Siraitia grosvenorii polysaccharide (SGP) from the Siraitia grosvenorii (Swingle) was isolated and puriﬁed. The therapeutic
eﬀects of SGP on diabetic rabbits induced by feeding high fat/high sucrose chow were studied. After administration of SGP for 4
weeks, the fasting blood glucose (FBG), plasma insulin levels (INS), plasma total cholesterol (TC), triglyceride (TG), and HDL-C
were assayed. The results showed that administration of SGP can signiﬁcantly decrease plasma total cholesterol, triglyceride, and
glucose levels; and increase HDL-C levels after 4 weeks of treatment. The antihyperglycaemic eﬀect of SGP at dose of 100mg·kg−1
bw was the most signiﬁcant in three dosage groups. Furthermore, SGP could restore the blood lipid levels of diabetic rabbits
(P<.05). These data indicate that SGP not only ameliorates the lipid disorder, but also lowers plasma glucose levels. So SGP have
obvious glucose-lowering eﬀect on hyperglycaemic rabbits induced by feeding high fat/high sucrose chow, its mechanism may be
related to amelioration of lipid metabolism and restoring the blood lipid levels of hyperglycaemic rabbits.
Copyright © 2007 Guo-Ping Lin et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Diabetes is a common endocrine-metabolic disease with
rising incidence in recent years. It is the third most life-
threatening disease whose mortality is right after cancer and
cardiovascular disease. Research and development of drugs
against diabetes and its complications have been getting
more and more attentions. Many types of polysaccharides,
isolated from herbal medicine, have been proved to have ef-
fects of lowering the blood glucose and lipids level in ani-
m a lm o d e l so fd i a b e t e s[ 1–4]. Progresses in research of these
herbal medicines may open up new and important ways in
treating diabetes.
MangosteenisamedicinalplantuniqueinChina,mainly
in the southern Guangxi and Hunan, with features of tasted
sweet, being cool, and nontoxic. In clinical practice, it can
heal cough, relieve fever, and promote digestion/excretion.
It has been widely used in the treatment of laryngitis, bron-
chitis, and gastrointestinal diseases in traditional Chinese
medicine. The previous study about Mangosteen has been
conﬁned to its sweet glycoside which account for about only
2% of its dry weight [1–3], without much being mentioned
about its polysaccharide components puriﬁcation and bio-
logical activity. This research was focused on puriﬁcation of
polysaccharide components, its regulatory role on high-fat-
high-sugar-induced diabetes in New Zealand’s rabbits.
2. MATERIALS AND METHODS
2.1. Materials
Siraitia grosvenorii was obtained from the Hengyang Medi-
cine Company (Hunan, China). Sucrose was obtained from
Liuzhou Sugar Company (Guangxi, China). Lard was ob-
tained from Hengyang Meat Product Company (Hunan,
China). Sephadex G-200 column and DEAE-cellulose col-
umn were from Whatman (Beijing, China). All other chem-
icals used were high-grade commercially available products.
2.2. IsolationandpuriﬁcationoftheSiraitia
grosvenoriipolysaccharide(SGP)
The polysaccharides were extracted from Siraitia grosvenorii
with boiling water or enzyme digestion with pancreatin. In
brief,dryfruitoftheplant(100g)wasfragmentedandboiled
in water for 5 hours. Filtrate was collected after it was cooled
to room temperature; or pancreatin was added to the 100g
fragmented dry fruit and stirred at 40◦Cf o r4h o u r s .F i l t r a t e
wascollectedafter1-hourboilingtoinactivatethepancreatin2 Experimental Diabetes Research
Table 1: Eﬀects of SGP on fasting glucose and insulin levels after high fat/high sucrose feeding in New Zealand white rabbits (n = 6p e r
group). Data are expressed as means ±SD. ∗P<. 05 and ∗∗P<. 01 versus control group.
Group Dose fasting blood glucose plasma insulin levels
mg·kg−1 bw /mmol·L−1 /µU·ml−1
A (normal group) — 4.31 ±0.58∗∗ 14.4 ±9.8
B (control group) — 7.36 ±0.76 13.8 ±12.5
C (SGP group) 50 6.18 ±0.43∗ 17.6 ±8.7
D (SGP group) 100 4.52 ±0.37∗∗ 14.9 ±7.9
E (SGP group) 200 4.68 ±0.81∗∗ 17.0 ±10.5
and cooling to room temperature. The crude polysaccha-
rides were obtained by 95% ethanol precipitation overnight
followed by washing with ethanol/acetone and vacuum dry-
ing. DEAE chromatography was performed after the precip-
itate was dissolved with H2O. Elute peaks, monitored us-
ing Sulfate-Phenol method, were combined and applied to
Sephadex G-200. Peaks were eluted with H2Oo rn o r m a l
saline and combined, followed by 95% ethanol precipita-
tion, washing with acetone/ether, and vacuum drying. The
Siraitia grosvenorii polysaccharide (SGP) was obtained and
the yield was 1.2% (extracted with boiling water) and 2.3%
(extracted enzyme digestion with pancreatin). The total car-
bohydrate amount was 46.8% and 42.6%, respectively, using
Sulfate-Phenol measurement. UV scanning spectrum shows
that there are no absorption peaks of protein and nuclear
acid at 280nm and 260nm.
2.3. Animalsexperiments
Male New Zealand white rabbits weighing approximately
2kg were obtained from the Shen Wan Ranch (Shanghai,
China). The animals were maintained at a 12-hour light-
dark cycle and a constant temperature of 23 ± 2◦C. Thirty
male New Zealand white rabbits were randomly assigned
into ﬁve groups: group A: the normal control which received
regular rabbit chow (Standard laboratory chow, Shen Wan
Experimental Animal Ranch, Shanghai, China) for 8 weeks
(Normal group); group B: the control which was fed high
fat/high sucrose chow (incorporating 10% lard and 37% su-
crose into the standard laboratory chow [4, 5], prepared in
our institute) for 8 weeks (Control group). group C-E: the
treated which was fed high fat/high sucrose chow (incorpo-
rating 10% lard and 37% sucrose into the standard labora-
tory chow) for the ﬁrst 4 weeks. From beginning of week 5,
SGP at dose of 50, 100, 200mg·kg−1 bw were supplemented,
respectively, into the high fat/high sucrose chow for the re-
maining4weeks(SGPgroup:groupC:atdoseof50mg·kg−1
bw SGP group; group D: 100mg·kg−1 b wS G Pg r o u p ;g r o u p
E: 200mg·kg−1 bw SGP group); All 5 groups were fed an
amount of 35g/kg/day (g per kg body weight and day). The
animals were fed at 9 am and given free access to tap wa-
ter. Food consumption was measured daily. Blood samples
for glucose, lipid, and insulin measurements were collected
from auricular veins after fasting overnight.
All animal experiments were approved by the local ani-
mal ethics committee of University of South China.
2.4. Analyticalmethods
Plasma total cholesterol (TC-test kit), HDL-C (HDL-C-test
kit),triglycerides(TG-testkit),andglucose(glucoseoxidase-
peroxidase method) were determined by commercially avail-
able enzymatic methods (Shanghai Rongsheng Biotech Inc,
Shanghai, China). Insulin was determined by conventional
radioimmunoassay, with the use of Insulin radioimmunol-
ogykit(BeijingInstituteofAtomicResearch,Beijing,China).
2.5. Statisticalanalysis
V a l u e sa r er e p o r t e da sm e a n s±SD. Comparisons between
groups were analyzed for statistical signiﬁcance using the
one-way analysis of variance, followed by the Dunnett’s test
multiple comparisons. P values less than .05 were considered
signiﬁcant.
3. RESULTS AND DISCUSSION
3.1. EffectsofSGPonfastingbloodglucose
andinsulinlevels
FastingbloodglucoselevelinrabbitsfromgroupB(theCon-
trol group) wasthe highest among 5 groups by the 8weeks of
high fat/high sucrose feeding. However, the increase of glu-
cose level was inhibited by supplementing SGP (SGP group).
SGP at dose of 100, 200mg·kg−1 bw signiﬁcantly lowered
the fasting blood glucose and the antihyperglycaemic eﬀect
of SGP at dose of 100mg·kg−1 bw was the most signiﬁcant
in three dosage groups (see Table 1).
There were no diﬀerences in plasma insulin levels among
thenormalgroup,thecontrolgroup,andtheSGPgroupdur-
ing the experimental period (see Table 1).
3.2. EffectsofSGPonplasmalipidlevels
Plasma total cholesterol levels in the control group were
higher than those in the normal group. Plasma total choles-
terol levels in the SGP group were lower than those in the
control group. Plasma triglyceride levels in the control group
were higher than those in the normal group. Plasma triglyc-
eride levels in the SGP group were lower than those in the
control group. Plasma HDL-C levels in the control group
were lower than those in the normal group. Plasma HDL-C
levels in the SGP group were higher than those in the control
group (see Table 2).Guo-Ping Lin et al. 3
Table 2: Eﬀects of SGP on plasma lipid levels after high fat/high sucrose feeding in New Zealand White rabbits (n = 6 per group). Data are
expressed as means ±SD. ∗P<. 05 and ∗∗P<. 01 versus Control group, ΔP<0.1 versus SGP 100 group.
Group Dose TC TG HDL-C
mg·kg−1 bw mmol·L−1 mmol·L−1 mmol·L−1
A (Normal group) — 1.75 ±0.26
∗∗Δ 0.94 ±0.16
∗∗Δ 1.62 ±0.21
∗∗Δ
B (Control group) — 2.76 ±0.43Δ 2.46 ±0.53Δ 0.89 ±0.15Δ
C (SGP group) 50 2.54 ±0.31Δ 2.04 ±0.36Δ 1.10 ±0.18Δ
D (SGP group) 100 2.03 ±0.23
∗ 1.56 ±0.27
∗∗ 1.47 ±0.14
∗∗
E (SGP group) 200 2.01 ±0.25
∗ 1.57 ±0.28
∗∗ 1.50 ±0.15
∗∗
Feeding high fat/high sucrose diets elevated plasma to-
tal cholesterol, triglyceride levels, and decreased HDL-C lev-
els. However, these changes were inhibited by supplement-
ing SGP into the high fat/high sucrose diets, and the eﬀect
of SGP at dose of 100mg·kg−1 bw was the most signiﬁcant
within the three dosage group.
The results are shown in Tables 1 and 2. High fat/high
sucrose increased plasma total cholesterol, triglyceride, and
glucose levels; and decreased HDL-C levels resulting in
atherosclerosis in the aorta. Administration of SGP to the
rabbitsresultedindecreasedplasmatotalcholesterol,triglyc-
eride, and glucose levels; and increased HDL-C levels after 4
weeks of treatment. There data indicate that SGP not only
ameliorates the lipid disorder, but also lowers plasma glucose
levels.
3.3. Discussion
Lipiddisorderindiabeticsubjectsisahighriskfactorforcar-
diovascular disease. Diabetes is a glucosedisorder and is usu-
ally accompanied with a lipid disorder. This may suggest that
the reduction of insulin sensitivity causes both glucose dis-
order and lipid disorder. Accordingly, this relationship may
indicate that amelioration of the glucose disorder induces
amelioration of the lipid disorder, and conversely, ameliora-
tion of the lipid disorder induces amelioration of the glucose
disorder.
In this study, we used high fat/high sucrose feeding-
induced type 2 diabetes rabbit model to determine the
eﬀects of SGP on atherosclerosis. In general, cholesterol-
fed rabbits have been a widely used model for experimen-
tal atherosclerosis research [6]. Our rabbit model showed
mild hypercholesterolemia and hypertriglyceridemia (con-
trol group, total cholesterol level: 2.76mmol·L−1,t r i g l y c -
eride level: 2.46mmol·L−1). This model also showed in-
creased plasma glucose levels (control group: 7.36 ± 0.76
mmol·L−1 versussnormalgroup:4.31±0.58). Therefore,the
characteristics of this model are mild type 2 diabetes with
high plasma glucose levels. Administration of SGP can sig-
niﬁcantly decrease plasma total cholesterol, triglyceride, and
glucoselevelsandelevateHDL-Clevelsafter4weeksoftreat-
ment in this rabbit model. Furthermore, SGP could restore
thebloodlipidlevelsofdiabeticrabbits(P <.05).Thismeans
that SGP has a therapeutic eﬀect by inhibiting the increase in
of plasma glucose in this rabbit model. However, this eﬀect
didnotcausetheplasmaglucoselevelstodroptolevelslower
than normal (normal group: 4.31 ± 0.58mmol·L−1 versus
SGP group: 4.52 ±0.37mmol·L−1).
These data indicate that SGP not only ameliorates the
lipid disorder, but also lowers plasma glucose levels. So SGP
haveobviousglucose-lowering eﬀectonhyperglycaemicrab-
bits induced by feeding high fat/high sucrose chow, its mech-
anism may be related to amelioration of lipid metabolism
and restoring the blood lipid levels of hyperglycaemic rab-
bits.
However, there were no diﬀerences in plasma insulin lev-
els among the normal group, the control group, and the SGP
group during the experimental period. We did not observe
any signiﬁcant eﬀect of SGP on fasting insulin, so the de-
crease of fasting glucose might be due to improved insulin
sensitivitythroughtheactionsofSGPonplasmatriglycerides
as shown in this study.
To our knowledge, this is the ﬁrst report in the world
about puriﬁcation of polysaccharides components from
Siraitia grosvenorii by enzyme digestion/ethanol precipi-
tation and DEAE/Sephadex G-200 chromatography. The
polysaccharides components SGP belong to acidic hetero-
polysaccharides, which composed of glucose, maltose, galac-
tose, arabinose, and so forth. They are potential polysaccha-
ride drugs which need further research about their composi-
tion and pharmacological eﬀect.
In summary, SGP signiﬁcantly decreased plasma to-
tal cholesterol, triglyceride, and glucose levels and elevated
HDL-C levels in rabbits with high fat/high sucrose-feeding-
induced mild diabetes type 2. Therefore, SGP is potentially
beneﬁcial for the treatment of hyperglycaemia and lipid dis-
order which are commonly associated with diabetes.
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